In similar application of OMVs by Gujrati et al.[51], E. coli was engineered to express human anti-Her-2 protein with reduced endotoxicity toward human cells and with an ability to kill cancer cells by delivering small interfering RNA (siRNA) via targeting kinesin spindle protein (KSP). This evidence concerns the gene ERBB2 and cancer.